Race, ethnicity and income as factors for HPV vaccine acceptance and use

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 7, 2013, Pages 1413-1420

  Jeudin, Patricia ^a   Liveright, Elizabeth ^a   Del Carmen, Marcela G ^b   Perkins, Rebecca B ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

HPV vaccine; Income; Pediatrics; Policy; Racial disparities; Review; Vaccine acceptance; Vaccine uptake; Vaccinology

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; AFRICAN AMERICAN; AFRICAN CARIBBEAN; ASIAN; ATTITUDE TO HEALTH; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER SCREENING; CONFERENCE PAPER; EDUCATIONAL STATUS; ETHNICITY; HEALTH DISPARITY; HIGH RISK POPULATION; HISPANIC; HUMAN; INCOME; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; PACIFIC ISLANDER; PAPILLOMAVIRUS INFECTION; POVERTY; RACE; RACE DIFFERENCE; RISK ASSESSMENT; RISK FACTOR; UTERINE CERVIX CANCER;

HPV VACCINE; INCOME; PEDIATRICS; POLICY; RACIAL DISPARITIES; REVIEW; VACCINE ACCEPTANCE; VACCINE UPTAKE; VACCINOLOGY;

ADOLESCENT; ETHNIC GROUPS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTHCARE DISPARITIES; HUMANS; IMMUNIZATION PROGRAMS; MEDICATION ADHERENCE; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; POVERTY; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 84880862193     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.24422     Document Type: Conference Paper

References (117)

1. SEER. http://seer.cancer.gov/statfacts/html/cervix.html- incidence-mortality. Accessed 10/7/11 2011.
2. CDC. HPV-Associated Cancers and Poverty Levels. http://wwwcdcgov/cancer/ hpv/statistics/povertyhtm 2009; Accessed Feb 27, 2012.
3. Clifford G, Franceschi S, Diaz M, Muñoz N, Villa LL. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases. Vaccine 2006; 24(Suppl 3):S3, 26-34; PMID:16950015; http://dx.doi.org/10.1016/j. vaccine.2006.05.026.
4. Hariri S, Unger ER, Sternberg M, Dunne EF, Swan D, Patel S, et al. Prevalence of genital human papillomavirus among females in the United States, the National Health And Nutrition Examination Survey, 2003-2006. J Infect Dis 2011; 204:566-73; PMID:21791659; http://dx.doi.org/10.1093/infdis/jir341.
5. Kahn JA, Cooper HP, Vadaparampil ST, Pence BC, Weinberg AD, LoCoco SJ, et al. Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev 2009; 18:2325-32; PMID:19661092; http://dx.doi.org/10.1158/1055-9965.EPI-09-0184.
6. ACIP. Quadrivalent Human Papillomavirus Vaccine: Recommendations of the Advisory Comitte on Immunization Practices. MMWR Recomm Rep 2007; 56:1.
7. Centers for Disease Control and Prevention (CDC). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010; 59:626-9; PMID:20508593.
8. Eaton DK, Kann L, Kinchen S, Shanklin S, Flint KH, Hawkins J, et al.; Centers for Disease Control and Prevention (CDC). Youth risk behavior surveillance - United States, 2011. MMWR Surveill Summ 2012; 61:1-162; PMID:22673000.
9. Opel DJ, Robinson JD, Heritage J, Korfiatis C, Taylor JA, Mangione-Smith R. Characterizing providers' immunization communication practices during health supervision visits with vaccine-hesitant parents: a pilot study. Vaccine 2012; 30:1269-75; PMID:22230593; http://dx.doi.org/10.1016/j.vaccine.2011.12.129.
10. Gainforth HL, Cao W, Latimer-Cheung AE. Message framing and parents' intentions to have their children vaccinated against HPV. Public Health Nurs 2012; 29:542-52; PMID:23078425; http://dx.doi.org/10.1111/j.1525-1446.2012. 01038.x.
11. Roche KC, Wiechens N, Owen-Hughes T, Perkins ND. The FHA domain protein SNIP1 is a regulator of the cell cycle and cyclin D1 expression. Oncogene 2004; 23:8185-95; PMID:15378006; http://dx.doi.org/10.1038/sj.onc.1208025.
12. CDC. Vaccines for Children Program. 2012.
13. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, et al. Prevalence of HPV infection among females in the United States. JAMA 2007; 297:813-9; PMID:17327523; http://dx.doi.org/10.1001/jama.297.8.813.
14. Olshen E, Woods ER, Austin SB, Luskin M, Bauchner H. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health 2005; 37:248-51; PMID:16109349; http://dx.doi.org/10.1016/j.jadohealth.2005.05.016.
15. Brawner BM, Baker JL, Voytek CD, et al. The Development of a Culturally Relevant, Theoretically Driven HPV Prevention Intervention for Urban Adolescent Females and Their Parents/Guardians. Health Promot Pract 2012.
16. Perkins RB, Pierre-Joseph N, Marquez C, Iloka S, Clark JA. Why do low-income minority parents choose human papillomavirus vaccination for their daughters? J Pediatr 2010; 157:617-22; PMID:20472250; http://dx.doi.org/10.1016/ j.jpeds.2010.04.013.
17. Scarinci IC, Garcés-Palacio IC, Partridge EE. An examination of acceptability of HPV vaccination among African American women and Latina immigrants. J Womens Health (Larchmt) 2007; 16:1224-33; PMID:17937576; http://dx.doi.org/10.1089/jwh.2006.0175.
18. Cook RL, Zhang J, Mullins J, Kauf T, Brumback B, Steingraber H, et al. Factors associated with initiation and completion of human papillomavirus vaccine series among young women enrolled in Medicaid. J Adolesc Health 2010; 47:596-9; PMID:21094437; http://dx.doi.org/10.1016/j.jadohealth.2010.09.015.
19. Chao C, Velicer C, Slezak JM, Jacobsen SJ. Correlates for human papillomavirus vaccination of adolescent girls and young women in a managed care organization. Am J Epidemiol 2010; 171:357-67; PMID:20047978;http://dx.doi.org/ 10.1093/aje/kwp365.
20. Kester LM, Zimet GD, Fortenberry JD, Kahn JA, Shew ML. A National Study of HPV Vaccination of Adolescent Girls: Rates, Predictors, and Reasons for Non-Vaccination. Matern Child Health J 2012; PMID:22729660; http://dx.doi.org/ 10.1007/s10995-012-1066-z.
21. Paavonen J, Naud P, Salmerón J, Wheeler CM, Chow SN, Apter D, et al.; HPV PATRICIA Study Group. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009; 374:301-14;PMID:19586656; http://dx.doi.org/10.1016/S0140-6736(09)61248-4.
22. Group FIS; FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007; 356:1915-27; PMID:17494925; http://dx.doi.org/10.1056/NEJMoa061741.
23. Goldman A, Schwartz McDonald S. The group depth interview: Principles and practice. Englewood Cliffs, NJ: Prentice-Hall.; 1987.
24. Widdice LE, Bernstein DI, Leonard AC, Marsolo KA, Kahn JA. Adherence to the HPV vaccine dosing intervals and factors associated with completion of 3 doses. Pediatrics 2011; 127:77-84; PMID:21149425; http://dx.doi.org/10.1542/ peds.2010-0812.
25. Niccolai LM, Mehta NR, Hadler JL. Racial/Ethnic and poverty disparities in human papillomavirus vaccination completion. Am J Prev Med 2011; 41:428-33; PMID:21961471; http://dx.doi.org/10.1016/j.amepre.2011.06.032.
26. Read DS, Joseph MA, Polishchuk V, Suss AL. Attitudes and perceptions of the HPV vaccine in Caribbean and African-American adolescent girls and their parents. J Pediatr Adolesc Gynecol 2010; 23:242-5; PMID:20452260; http://dx.doi.org/10.1016/j.jpag.2010.02.002.
27. Poole JC, Thain A, Perkins ND, Roninson IB. Induction of transcription by p21Waf1/Cip1/Sdi1: role of NFkappaB and effect of non-steroidal anti-inflammatory drugs. Cell Cycle 2004; 3:931-40; PMID:15190207; http://dx.doi.org/10.4161/cc.3.7.971.
28. Kobetz E, Menard J, Hazan G, Koru-Sengul T, Joseph T, Nissan J, et al. Perceptions of HPV and cervical cancer among Haitian immigrant women: implications for vaccine acceptability. Educ Health (Abingdon) 2011; 24:479; PMID:22267344.
29. Gust DA, Darling N, Kennedy A, Schwartz B. Parents with doubts about vaccines: which vaccines and reasons why. Pediatrics 2008; 122:718-25; PMID:18829793;http://dx.doi.org/10.1542/peds.2007-0538.
30. Opel DJ, Taylor JA, Mangione-Smith R, Solomon C, Zhao C, Catz S, et al. Validity and reliability of a survey to identify vaccine-hesitant parents. Vaccine 2011; 29:6598-605; PMID:21763384; http://dx.doi.org/10.1016/j.vaccine. 2011.06.115.
31. Podolsky R, Cremer M, Atrio J, Hochman T, Arslan AA. HPV vaccine acceptability by Latino parents: a comparison of U.S. and Salvadoran populations. J Pediatr Adolesc Gynecol 2009; 22:205-15; PMID:19646665;http://dx. doi.org/10.1016/j.jpag.2008.05.010.
32. Sanderson M, Coker AL, Eggleston KS, Fernandez ME, Arrastia CD, Fadden MK. HPV vaccine acceptance among Latina mothers by HPV status. J Womens Health (Larchmt) 2009; 18:1793-9; PMID:19951213; http://dx.doi.org/10.1089/jwh.2008. 1266.
33. Yeganeh N, Curtis D, Kuo A. Factors influencing HPV vaccination status in a Latino population; and parental attitudes towards vaccine mandates. Vaccine 2010; 28:4186-91; PMID:20417261; http://dx.doi.org/10.1016/j.vaccine.2010.04. 010.
34. Bastani R, Glenn BA, Tsui J, Chang LC, Marchand EJ, Taylor VM, et al. Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls. Cancer Epidemiol Biomarkers Prev 2011; 20:1463-72; PMID:21602307; http://dx.doi.org/10.1158/1055-9965.EPI-11-0267.
35. NIS-Teen. Vaccination coverage among adolescents aged 13-17 years - United States, 2008 NIS-Teen. Accessed January 12, 2010. http://wwwcdcgov/ vaccines/stats-surv/nisteen/tables/08/tab14-HPV1-racexls 2010.
36. Centers for Disease Control and Prevention (CDC). National and state vaccination coverage among adolescents aged 13 through 17 years-United States, 2010. MMWR Morb Mortal Wkly Rep 2011; 60:1117-23; PMID:21866084.
37. Davis TC, Williams MV, Marin E, Parker RM, Glass J. Health literacy and cancer communication. CA Cancer J Clin 2002; 52:134-49; PMID:12018928; http://dx.doi.org/10.3322/canjclin.52.3.134.
38. Perkins RB, Langrish SM, Stern LJ, Figueroa J, Simon CJ. Comparison of visual inspection and Papanicolau (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned? Trop Med Int Health 2007; 12:1018-25; PMID:17875013; http://dx.doi.org/10.1111/j.1365-3156.2007.01888.x.
39. Denny L. The prevention of cervical cancer in developing countries. BJOG 2005; 112:1204-12; PMID:16101597; http://dx.doi.org/10.1111/j.1471-0528.2005. 00713.x.
40. Perkins RB, Langrish SM, Cotton DJ, Simon CJ. Maternal support for human papillomavirus vaccination in Honduras. J Womens Health (Larchmt) 2011; 20:85-90; PMID:21091226; http://dx.doi.org/10.1089/jwh.2009.1919.
41. Prislin R, Nader PR, De Guire M, Hoy PL, Pung MA, Ross S, et al. Physicians' immunization knowledge, attitudes, and practices: a valid and internally consistent measurement tool. Am J Prev Med 1999; 17:151-2; PMID:10490060; http://dx.doi.org/10.1016/S0749-3797(99)00054-9.
42. Crabtree BF, Miller WL, Tallia AF, Cohen DJ, DiCicco- Bloom B, McIlvain HE, et al. Delivery of clinical preventive services in family medicine offices. Ann Fam Med 2005; 3:430-5; PMID:16189059; http://dx.doi.org/10.1370/afm.345.
43. McCracken M, Olsen M, Chen MS Jr., Jemal A, Thun M, Cokkinides V, et al. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin 2007; 57:190-205; PMID:17626117; http://dx.doi.org/10.3322/canjclin.57.4. 190.
44. Constantine NA, Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health 2007; 40:108-15; PMID:17259050; http://dx.doi.org/10.1016/j. jadohealth.2006.10.007.
45. Jaén CR, Stange KC, Nutting PA. Competing demands of primary care: a model for the delivery of clinical preventive services. J Fam Pract 1994; 38:166-71;PMID:8308509.
46. Miller WRRS. Motivational Interviewing: Helping People Change. 3rd ed. New York: Guilford Press; 2012.
47. The Dartmouth Atlas of Healthcare. 2012 (Accessed January 17, 2013, at http://www.dartmouthatlas.org/keyissues/issue.aspx?con=2939).
48. Eppes C, Wu A, Cameron KA, Garcia P, Grobman W. Does obstetrician knowledge regarding influenza increase HINI vaccine acceptance among their pregnant patients? Vaccine 2012; 30:5782-4; PMID:22743135; http://dx.doi.org/10. 1016/j.vaccine.2012.06.032.
49. Do H, Seng P, Talbot J, Acorda E, Coronado GD, Taylor VM. HPV vaccine knowledge and beliefs among Cambodian American parents and community leaders. Asian Pac J Cancer Prev 2009; 10:339-44; PMID:19640169.
50. Salmon DA, Sotir MJ, Pan WK, Berg JL, Omer SB, Stokley S, et al. Parental vaccine refusal in Wisconsin: a case-control study. WMJ 2009; 108:17-23; PMID:19326630.
51. Leddy MA, Anderson BL, Power ML, Gall S, Gonik B, Schulkin J. Changes in and current status of obstetrician-gynecologists' knowledge, attitudes, and practice regarding immunization. Obstet Gynecol Surv 2009; 64:823-9; PMID:19939296; http://dx.doi.org/10.1097/OGX.0b013e3181c4bbb7.
52. Perkins RB, Hall JE, Martin KA. Neuroendocrine abnormalities in hypothalamic amenorrhea: spectrum, stability, and response to neurotransmitter modulation. J Clin Endocrinol Metab 1999; 84:1905-11; PMID:10372685; http://dx.doi.org/10.1210/jc.84.6.1905.
53. Rosenthal SL, Rupp R, Zimet GD, Meza HM, Loza ML, Short MB, et al. Uptake of HPV vaccine: demographics, sexual history and values, parenting style, and vaccine attitudes. J Adolesc Health 2008; 43:239-45; PMID:18710678; http://dx.doi.org/10.1016/j.jadohealth.2008.06.009.
54. Zimet GD, Mays RM, Sturm LA, Ravert AA, Perkins SM, Juliar BE. Parental attitudes about sexually transmitted infection vaccination for their adolescent children. Arch Pediatr Adolesc Med 2005; 159:132-7; PMID:15699306; http://dx.doi.org/10.1001/archpedi.159.2.132.
55. Halperin S. How to manage parents unsure about immunization. Can J Contin Med Educ 2000; 12:62-74.
56. Akers AY, Newmann SJ, Smith JS. Factors underlying disparities in cervical cancer incidence, screening, and treatment in the United States. Curr Probl Cancer 2007; 31:157-81; PMID:17543946; http://dx.doi.org/10.1016/j. currproblcancer.2007.01.001
57. Lee MC. Knowledge, barriers, and motivators related to cervical cancer screening among Korean-American women. A focus group approach. Cancer Nurs 2000; 23:168-75; PMID:10851767; http://dx.doi.org/10.1097/00002820-200006000-00003.
58. Powe BD, Finnie R. Cancer fatalism: the state of the science. Cancer Nurs 2003; 26:454-65, quiz 466-7; PMID:15022977; http://dx.doi.org/10.1097/00002820- 200312000-00005.
59. Vanslyke JG, Baum J, Plaza V, Otero M, Wheeler C, Helitzer DL. HPV and cervical cancer testing and prevention: knowledge, beliefs, and attitudes among Hispanic women. Qual Health Res 2008; 18:584-96; PMID:18337618; http://dx.doi.org/10.1177/1049732308315734.
60. Garbers S, Chiasson MA. Inadequate functional health literacy in Spanish as a barrier to cervical cancer screening among immigrant Latinas in New York City. Prev Chronic Dis 2004; 1:A07; PMID:15670438.
61. Downs LS, Smith JS, Scarinci I, Flowers L, Parham G. The disparity of cervical cancer in diverse populations. Gynecol Oncol 2008; 109(Suppl):S22-30; PMID:18482555; http://dx.doi.org/10.1016/j.ygyno.2008.01.003.
62. Brooks SE, Chen TT, Ghosh A, Mullins CD, Gardner JF, Baquet CR. Cervical cancer outcomes analysis: impact of age, race, and comorbid illness on hospitalizations for invasive carcinoma of the cervix. Gynecol Oncol 2000; 79:107-15; PMID:11006041; http://dx.doi.org/10.1006/gyno.2000.5901.
63. Grieb SM, Davey-Rothwell M, Latkin CA. Social and sexual network characteristics and concurrent sexual partnerships among urban African American high-risk women with main sex partners. AIDS Behav 2012; 16:882-9; PMID:21861193; http://dx.doi.org/10.1007/s10461-011-0030-z.
64. Population Projections. 2012. (Accessed December 1, 2012, at http://www.census.gov/population/projections/data/national/2012/summarytables. html.)
65. Kimmel S. Adolescent Vaccination: Physician Challenges and Solutions. J Adolesc Health 2010; 46:S16-23; http://dx.doi.org/10.1016/j.jadohealth.2009.11. 219.
66. Cohen NJ, Lauderdale DS, Shete PB, Seal JB, Daum RS. Physician knowledge of catch-up regimens and contraindications for childhood immunizations. Pediatrics 2003; 111:925-32; PMID:12728067; http://dx.doi.org/10.1542/peds.111. 5.925.
67. Davis D, O'Brien MA, Freemantle N, Wolf FM, Mazmanian P, Taylor-Vaisey A. Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes? JAMA 1999; 282:867-74; PMID:10478694; http://dx.doi.org/10.1001/jama.282.9.867.
68. Performance improvement CME: Core of the new CME. 2007. (Accessed January 19, 2013, at http://www.ama-assn.org/resources/doc/cme/cppd22.pdf.)
69. Mazmanian PE, Davis DA. Continuing medical education and the physician as a learner: guide to the evidence. JAMA 2002; 288:1057-60; PMID:12204068; http://dx.doi.org/10.1001/jama.288.9.1057.
70. Dempsey AF, Davis MM. Overcoming barriers to adherence to HPV vaccination recommendations. Am J Manag Care 2006; 12(Suppl):S484-91; PMID:17203992.
71. Moyer JH, Perkins RB. Experimental studies on the toxicity of amithiozone in dogs. Am Rev Tuberc 1951; 64:659-68; PMID:14885696.
72. Flanagan-Klygis EA, Sharp L, Frader JE. Dismissing the family who refuses vaccines: a study of pediatrician attitudes. Arch Pediatr Adolesc Med 2005; 159:929-34; PMID:16203937; http://dx.doi.org/10.1001/archpedi.159.10.929.
73. Healy CM, Pickering LK. How to communicate with vaccine-hesitant parents. Pediatrics 2011; 127(Suppl 1):S127-33; PMID:21502238; http://dx.doi.org/10. 1542/peds.2010-1722S.
74. Jones TB, Bailey BA, Sokol RJ. Alcohol Use in Pregnancy: Insights in Screening and Intervention for the Clinician Clin Obstet Gynecol 2013.
75. Klimas J, Field CA, Cullen W, O'Gorman CS, Glynn LG, Keenan E, et al. Psychosocial interventions to reduce alcohol consumption in concurrent problem alcohol and illicit drug users: Cochrane Reviewa. Syst Rev 2013; 2:3; PMID:23311684; http://dx.doi.org/10.1186/2046-4053-2-3.
76. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007; 45:107-14; PMID:17628649; http://dx.doi.org/10.1016/j.ypmed.2007.05.013.
77. Conroy K, Rosenthal SL, Zimet GD, Jin Y, Bernstein DI, Glynn S, et al. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health (Larchmt) 2009; 18:1679-86; PMID:19785564; http://dx.doi.org/10.1089/jwh.2008.1329.
78. Guerry SL, De Rosa CJ, Markowitz LE, Walker S, Liddon N, Kerndt PR, et al. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine 2011; 29:2235-41; PMID:21288799; http://dx.doi.org/10.1016/ j.vaccine.2011.01.052.
79. Perkins RB, Apte G, Marquez C, Porter C, Belizaire M, Clark JA, et al. Factors affecting human papillomavirus vaccine use among White, Black and Latino parents of sons. Pediatr Infect Dis J 2013; 32:e38-44; PMID:22914585; http://dx.doi.org/10.1097/INF.0b013e31826f53e3.
80. Bartlett JA, Peterson JA. The uptake of Human Papillomavirus (HPV) vaccine among adolescent females in the United States: a review of the literature. J Sch Nurs 2011; 27:434-46; PMID:21750234; http://dx.doi.org/10. 1177/1059840511415861.
81. Dorell CG, Yankey D, Santibanez TA, Markowitz LE. Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics 2011; 128:830-9; PMID:22007006; http://dx.doi.org/10.1542/peds.2011-0950.
82. Litton AG, Desmond RA, Gilliland J, Huh WK, Franklin FA. Factors associated with intention to vaccinate a daughter against HPV: a statewide survey in Alabama. J Pediatr Adolesc Gynecol 2011; 24:166-71; PMID:21397534; http://dx.doi.org/10.1016/j.jpag.2011.01.004.
83. Dorell C, Yankey D, Strasser S. Parent-reported reasons for nonreceipt of recommended adolescent vaccinations, national immunization survey: teen, 2009. Clin Pediatr (Phila) 2011; 50:1116-24; PMID:21856964; http://dx.doi.org/10.1177/ 0009922811415104.
84. Lau M, Lin H, Flores G. Factors associated with human papillomavirus vaccine-series initiation and healthcare provider recommendation in US adolescent females: 2007 National Survey of Children's Health. Vaccine 2012; 30:3112-8; PMID:22425179; http://dx.doi.org/10.1016/j.vaccine.2012.02.034.
85. Rosenthal SL, Weiss TW, Zimet GD, Ma L, Good MB, Vichnin MD. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine 2011; 29:890-5; PMID:20056186; http://dx.doi.org/10. 1016/j.vaccine.2009.12.063.
86. Mehta NR, Julian PJ, Meek JI, Sosa LE, Bilinski A, Hariri S, et al. Human papillomavirus vaccination history among women with precancerous cervical lesions: disparities and barriers. Obstet Gynecol 2012; 119:575-81; PMID:22353956; http://dx.doi.org/10.1097/AOG.0b013e3182460d9f.
87. Kahn JA, Rosenthal SL, Tissot AM, Bernstein DI, Wetzel C, Zimet GD. Factors influencing pediatricians' intention to recommend human papillomavirus vaccines. Ambul Pediatr 2007; 7:367-73; PMID:17870645; http://dx.doi.org/10. 1016/j.ambp.2007.05.010.
88. Schnatz PF, Humphrey K, O'Sullivan DM. Assessment of the perceptions and administration of the human papillomavirus vaccine. J Low Genit Tract Dis 2010; 14:103-7; PMID:20354417; http://dx.doi.org/10.1097/LGT.0b013e3181b240ca.
89. Young JL, Bernheim RG, Korte JE, Stoler MH, Guterbock TM, Rice LW. Human papillomavirus vaccination recommendation may be linked to reimbursement: a survey of Virginia family practitioners and gynecologists. J Pediatr Adolesc Gynecol 2011; 24:380-5; PMID:21906978; http://dx.doi.org/10.1016/j.jpag.2011.06. 016.
90. Askelson NM, Campo S, Lowe JB, Dennis LK, Smith S, Andsager J. Factors related to physicians' willingness to vaccinate girls against HPV: the importance of subjective norms and perceived behavioral control. Women Health 2010; 50:144-58; PMID:20437302; http://dx.doi.org/10.1080/03630241003705094.
91. Jensen ME, Hartenbach E, McElroy JA, Faerber A, Havighurst T, Kim KM, et al. Brief report: Measuring the attitudes of health care professionals in Dane County toward adolescent immunization with HPV vaccine. WMJ 2009; 108:203-5; PMID:19753828.
92. Tariq S, Bhakta S, Grimes A, Stevens A. Attitudes of Arkansas' primary care physicians toward the HPV vaccine. J Ark Med Soc 2009; 106:113-7; PMID:19899297.
93. Smith MJ, Woods CR, Marshall GS. Parental vaccine concerns in Kentucky. J Ky Med Assoc 2009; 107:342-9; PMID:19813430.
94. Sussman AL, Helitzer D, Sanders M, Urquieta B, Salvador M, Ndiaye K. HPV and cervical cancer prevention counseling with younger adolescents: implications for primary care. Ann Fam Med 2007; 5:298-304; PMID:17664495; http://dx.doi.org/10.1370/afm.723.
95. Tissot AM, Zimet GD, Rosenthal SL, Bernstein DI, Wetzel C, Kahn JA. Effective strategies for HPV vaccine delivery: the views of pediatricians. J Adolesc Health 2007; 41:119-25; PMID:17659214; http://dx.doi.org/10.1016/j. jadohealth.2007.05.007.
96. Saraiya M, Rosser JI, Cooper CP. Cancers that U.S. physicians believe the HPV vaccine prevents: findings from a physician survey, 2009. J Womens Health (Larchmt) 2012; 21:111-7; PMID:22216920; http://dx.doi.org/10.1089/jwh.2011. 3313.
97. Perkins RB, Clark JA. Providers' Attitudes Toward Human Papillomavirus Vaccination in Young Men: Challenges for Implementation of 2011 Recommendations. Am J Mens Health 2012.
98. Vadaparampil ST, Kahn JA, Salmon D, Lee JH, Quinn GP, Roetzheim R, et al. Missed clinical opportunities: provider recommendations for HPV vaccination for 11-12 year old girls are limited. Vaccine 2011; 29:8634-41; PMID:21924315; http://dx.doi.org/10.1016/j.vaccine.2011.09.006.
99. McCave EL. Influential factors in HPV vaccination uptake among providers in four states. J Community Health 2010; 35:645-52; PMID:20336354; http://dx.doi.org/10.1007/s10900-010-9255-4.
100. Barnack JL, Reddy DM, Swain C. Predictors of parents' willingness to vaccinate for human papillomavirus and physicians' intentions to recommend the vaccine. Womens Health Issues 2010; 20:28-34; PMID:20123174; http://dx.doi.org/10.1016/j.whi.2009.08.007.
101. Ishibashi KL, Koopmans J, Curlin FA, Alexander KA, Ross LF. Paediatricians' attitudes and practices towards HPV vaccination. Acta Paediatr 2008; 97:1550-6; PMID:18671696; http://dx.doi.org/10.1111/j.1651-2227.2008. 00958.x.
102. Gorin SS, Ashford AR, Lantigua R, Desai M, Troxel A, Gemson D. Implementing academic detailing for breast cancer screening in underserved communities. Implement Sci 2007; 2:43; PMID:18086311; http://dx.doi.org/10.1186/ 1748-5908-2-43.
103. Sheinfeld Gorin S, Gemson D, Ashford A, Bloch S, Lantigua R, Ahsan H, et al. Cancer education among primary care physicians in an underserved community. Am J Prev Med 2000; 19:53-8; PMID:10865164; http://dx.doi.org/10.1016/S0749- 3797(00)00153-7.
104. Mullikin EA, Ales MW, Cho J, Nelson TM, Rodrigues SB, Speight M. Sharing collaborative designs of tobacco cessation performance improvement CME projects. J Contin Educ Health Prof 2011; 31(Suppl 1):S37-49; PMID:22190100; http://dx.doi.org/10.1002/chp.20147.
105. Bair RM, Mays RM, Sturm LA, Zimet GD. Acceptability of the human papillomavirus vaccine among Latina mothers. J Pediatr Adolesc Gynecol 2008; 21:329-34; PMID:19064226; http://dx.doi.org/10.1016/j.jpag.2008.02.007.
106. Cates JR, Brewer NT, Fazekas KI, Mitchell CE, Smith JS. Racial differences in HPV knowledge, HPV vaccine acceptability, and related beliefs among rural, southern women. J Rural Health 2009; 25:93-7; PMID:19166567; http://dx.doi.org/10.1111/j.1748-0361.2009.00204.x.
107. McRee AL, Reiter PL, Brewer NT. Parents' Internet use for information about HPV vaccine. Vaccine 2012 30:3757-62; PMID:22172505.
108. Dempsey AF, Zimet GD, Davis RL, Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 2006; 117:1486-93; PMID:16651301; http://dx.doi.org/10.1542/peds.2005-1381.
109. Kouyoumdjian FG, Bailowitz A. Completion of the human papillomavirus vaccine series in females attending an urban immunization clinic. Pediatr Infect Dis J 2011; 30:718-9; PMID:21343841; http://dx.doi.org/10.1097/INF. 0b013e3182121426.
110. Hamlish T, Clarke L, Alexander KA. Barriers to HPV immunization for African American adolescent females. Vaccine 2012; 30:6472-6; PMID:22910288; http://dx.doi.org/10.1016/j.vaccine.2012.07.085.
111. Suh CA, Saville A, Daley MF, Glazner JE, Barrow J, Stokley S, et al. Effectiveness and net cost of reminder/recall for adolescent immunizations. Pediatrics 2012; 129:e1437-45; PMID:22566415; http://dx.doi.org/10.1542/peds. 2011-1714.
112. Gorin SS, Ashford AR, Lantigua R, Hossain A, Desai M, Troxel A, et al. Effectiveness of academic detailing on breast cancer screening among primary care physicians in an underserved community. J Am Board Fam Med 2006; 19:110-21; PMID:16513899; http://dx.doi.org/10.3122/jabfm.19.2.110.
113. Phillips CE, Rothstein JD, Beaver K, Sherman BJ, Freund KM, Battaglia TA. Patient navigation to increase mammography screening among inner city women. J Gen Intern Med 2011; 26:123-9; PMID:20931294; http://dx.doi.org/10.1007/s11606- 010-1527-2.
114. Gowda C, Schaffer SE, Dombkowski KJ, Dempsey AF. Understanding attitudes toward adolescent vaccination and the decision-making dynamic among adolescents, parents and providers. BMC Public Health 2012; 12:509; PMID:22768870; http://dx.doi.org/10.1186/1471-2458-12-509.
115. Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 2009; 20:417-35; PMID:19002764; http://dx.doi.org/10.1007/s10552-008-9256-0.
116. Chu KC, Miller BA, Springfield SA. Measures of racial/ethnic health disparities in cancer mortality rates and the influence of socioeconomic status. J Natl Med Assoc 2007; 99:1092-100, 1102-4; PMID:17987912.
117. 2011 NIS-Teen. 2012. (Accessed 12/29, 2012, at http://www.cdc.gov/ vaccines/stats-surv/nisteen/data/tables-2011.htm - race.)